{"id":1590,"date":"2018-01-17T13:33:39","date_gmt":"2018-01-17T12:33:39","guid":{"rendered":"http:\/\/semmelweis.hu\/symposium\/?page_id=1590"},"modified":"2018-10-09T08:52:29","modified_gmt":"2018-10-09T06:52:29","slug":"program","status":"publish","type":"page","link":"https:\/\/semmelweis.hu\/symposium\/szimpozium-archiv\/semmelweis-szimpozium-2018\/program\/","title":{"rendered":"Program &#8211; 2018"},"content":{"rendered":"<p><strong>Semmelweis Symposium &#8211; 2018<\/strong><\/p>\n<p><a href=\"https:\/\/semmelweis.hu\/symposium\/files\/2018\/10\/Semmelweis-Symposium-program-v20181009.pdf\" target=\"_blank\" rel=\"noopener\">Semmelweis Symposium 2018 program download<\/a><\/p>\n<p><strong>New approaches in personalized medicine: From prenatal testing to targeted tumor therapy<\/strong><\/p>\n<p><strong>Budapest, November 8-9, 2018<\/strong><\/p>\n<p>Basic Science Center, Semmelweis University, Budapest (T\u0171zolt\u00f3 37-43, Budapest, 1094, Hungary)<\/p>\n<p>Chairperson: Prof. P\u00e9ter Lakatos<\/p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\" width=\"697\">\n<p><strong>8th November<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>9.00-9.15<\/p>\n<\/td>\n<td width=\"593\">\n<p><em>Opening ceremony<\/em><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>9.15-10.55<\/p>\n<\/td>\n<td width=\"593\">\n<p><em>Section I. \u2013 Personalized Oncology I.<\/em><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>9.15-9.35<\/p>\n<\/td>\n<td width=\"593\">\n<p>Personalized medicine: What does that mean? Istv\u00e1n Tak\u00e1cs, Semmelweis University, Budapest, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>9.35-9.55<\/p>\n<\/td>\n<td width=\"593\">\n<p>Molecular biomarkers for the evaluation of colorectal cancer: Where are we now? Erika T\u00f3th, Orsz\u00e1gos Onkol\u00f3giai Int\u00e9zet, Budapest, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>9.55-10.15<\/p>\n<\/td>\n<td width=\"593\">\n<p>Every breast cancer patient needs chemotherapy? Magdolna Dank, Semmelweis University, Budapest, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>10.15-10.35<\/p>\n<\/td>\n<td width=\"593\">\n<p>The role of RANK-RANKL in osteology and malignancies. Zsolt Nagy, Semmelweis University, Budapest, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>10.35-10.55<\/p>\n<\/td>\n<td width=\"593\">\n<p>The evolution of molecular pathology; precision medicine in practice. Chris Allen, ThermoFisher Scientific, UK<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p><em>10.55-11.15<\/em><\/p>\n<\/td>\n<td width=\"593\">\n<p><em>Coffee Break<\/em><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p><em>11.15-12.55<\/em><\/p>\n<\/td>\n<td width=\"593\">\n<p><em>Section II. \u2013 Personalized Oncology II.<\/em><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>11.15-11.35<\/p>\n<\/td>\n<td width=\"593\">\n<p>The code and importance of liquid biopsy. Joao R. Carvalho, Biocartis, Mechelen, Netherlands<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>11.35-11.55<\/p>\n<\/td>\n<td width=\"593\">\n<p>BRCA1\/2 genes in clinical practice. Edit Ol\u00e1h, National Institute of Oncology, Budapest, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>11.55-12.15<\/p>\n<\/td>\n<td width=\"593\">\n<p>The biology and application of cell-free nucleic acids in the clinical diagnosis. B\u00e1lint Nagy, Debrecen University, Debrecen, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>12.15-12.35<\/p>\n<\/td>\n<td width=\"593\">\n<p>Personalized approach to thyroid nodules. Juan Carlos Galofr\u00e9, University of Navarra, Pamplona, Spain<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>12.35-12.55<\/p>\n<\/td>\n<td width=\"593\">\n<p>Molecular diagnostics of thyroid cancers. P\u00e9ter Lakatos, Semmelweis University, Budapest, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>12.55-14.00<\/p>\n<\/td>\n<td width=\"593\">\n<p><em>Lunch<\/em><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>14.00-15.20<\/p>\n<\/td>\n<td width=\"593\">\n<p><em>Section III. \u2013 Prenatal genetics <\/em><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>14.00-14.20<\/p>\n<\/td>\n<td width=\"593\">\n<p>Non-invasive prenatal testing (NIPT). J\u00e1nos P. K\u00f3sa, Semmelweis University, Budapest, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>14.20-14.40<\/p>\n<\/td>\n<td width=\"593\">\n<p>SNP based NIPT, aneuploidy and single gene mutations. Trudy McKanna, Natera, San Carlos, CA, USA<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>14.40-15.00<\/p>\n<\/td>\n<td width=\"593\">\n<p>Comparative genomic hybridization arrays or conventional karyotyping? Olga T\u00f6r\u00f6k, Debrecen Egyetem, Debrecen, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>15.00-15.20<\/p>\n<\/td>\n<td width=\"593\">\n<p>Preimplantational diagnostics: designer babies? P\u00e9ter Fancsovics, Semmelweis University, Budapest, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>15.20-15.40<\/p>\n<\/td>\n<td width=\"593\">\n<p>Graduated diagnosis and personalized therapy of rare diseases in pediatrics. Gy\u00f6rgy Fekete, Semmelweis University, Budapest, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>15.40-16.00<\/p>\n<\/td>\n<td width=\"593\">\n<p><em>Coffee Break<\/em><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>16.00-17.20<\/p>\n<\/td>\n<td width=\"593\">\n<p><em>Section IV. \u2013 Endocrinology \/ Osteology <\/em><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>16.00-16.20<\/p>\n<\/td>\n<td width=\"593\">\n<p>Sequential therapy of osteoporosis. P\u00e9ter Lakatos, Semmelweis University, Budapest, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>16.20-16.40<\/p>\n<\/td>\n<td width=\"593\">\n<p>Treatment of diabetes by stem cells. Antony Gavalas, Dresden University of Applied Sciences, Dresden,Germany<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>16.40-17.00<\/p>\n<\/td>\n<td width=\"593\">\n<p>Familial hypercholesterinemia \u2013 PCSK-9 inhibition. Gy\u00f6rgy Paragh, Debrecen University, Debrecen, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>17.00-17.20<\/p>\n<\/td>\n<td width=\"593\">\n<p>High throughput methods in the evaluation of tumorigenesis in endocrine tumors. Attila Pat\u00f3cs, Semmelweis University, Budapest, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>&nbsp;<\/p>\n<\/td>\n<td width=\"593\">\n<p><em>\u00a0<\/em><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>19.00-22.00<\/p>\n<\/td>\n<td width=\"593\">\n<p><em>Official Dinner Event (River Danube Experience)<\/em><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"2\" width=\"697\">\n<p><strong>9th November<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>9.00-10.40<\/p>\n<\/td>\n<td width=\"593\">\n<p><em>Section V. \u2013 Hematology<\/em><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>9.00-9.20<\/p>\n<\/td>\n<td width=\"593\">\n<p>BITE-ing in the leukemia. Judit Demeter, Semmelweis University, Budapest, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>9.20-9.40<\/p>\n<\/td>\n<td width=\"593\">\n<p>Personalized diagnostics and therapy in oncohematological malignancies. Csaba B\u00f6d\u00f6r, Semmelweis University, Budapest, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>9.40-10.00<\/p>\n<\/td>\n<td width=\"593\">\n<p>NGS in hematology. Torsten Haferlach, M\u00fcnchner Leuk\u00e4mielabor, M\u00fcnchen, Germany<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>10.00-10.20<\/p>\n<\/td>\n<td width=\"593\">\n<p>Chimeric Antigen Receptor (CAR) T-Cell Therapy in hematology. Tam\u00e1s Masszi, Semmelweis University, Budapest, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>10.20-10.40<\/p>\n<\/td>\n<td width=\"593\">\n<p>Virus-specific T cell therapy in allogenic hematopoietic stem cell transplantation. Kriszti\u00e1n K\u00e1llay, D\u00e9l-Pesti Medical Center and National Institute for Hematology and Infectology, Budapest, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p><em>10.40-11.00<\/em><\/p>\n<\/td>\n<td width=\"593\">\n<p><em>Coffee Break<\/em><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p><em>11.00-13.00<\/em><\/p>\n<\/td>\n<td width=\"593\">\n<p><em>Section VI. \u2013 Rare diseases<\/em><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>11.00-11.20<\/p>\n<\/td>\n<td width=\"593\">\n<p>Langerhans cell histiocytosis \u2013 from inflammation to malignancy. Michael Girschikofsky, Ordensklinikum, Linz, Austria<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>11.20-11.40<\/p>\n<\/td>\n<td width=\"593\">\n<p>Ending the diagnostic odyssey of rare diseases: NGS in the clinic. Krist\u00f3f \u00c1rvai, Semmelweis University, Budapest, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>11.40-12.00<\/p>\n<\/td>\n<td width=\"593\">\n<p>Enzyme replacement therapies for lysosomal storage diseases. Francisca Coutinho, National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>12.00-12.20<\/p>\n<\/td>\n<td width=\"593\">\n<p>Live and let die. What genetics can offer for patients with cardiac disease: blessing or damn? G\u00e1bor Uzonyi, Uzsoki Hospital, Budapest, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>12.20-12.40<\/p>\n<\/td>\n<td width=\"593\">\n<p>Whole exome sequencing in the management of rare diseases. Judit\u00a0 M\u00e1ria Moln\u00e1r, Semmelweis University, Budapest, Hungary<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>12.40-13.40<\/p>\n<\/td>\n<td width=\"593\">\n<p><em>Lunch<\/em><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>13.40-15.20<\/p>\n<\/td>\n<td width=\"593\">\n<p><em>Section VII. \u2013 Emerging Techniques<\/em><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>13.40-14.00<\/p>\n<\/td>\n<td width=\"593\">\n<p>Cell metabolism revealed: Agilent Seahorse XF, Svetoslav Kalaydiev, Agilent, Stockport, UK<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>14.00-14.20<\/p>\n<\/td>\n<td width=\"593\">\n<p>CRISPR \/ Base editing. Marie-Christine Birling, Institute Clinique de la Souris, Illkirch-Graffenstaden, France<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>14.20-14.40<\/p>\n<\/td>\n<td width=\"593\">\n<p>Lessons from limb regeneration in salamanders. Dunja Knapp, DFG- Center for Regenerative Therapies Dresden, Dresden, Germany<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>14.40-15.00<\/p>\n<\/td>\n<td width=\"593\">\n<p>Nanostring digital optical barcode technology: innovations in spatially resolved, library free multi-analyte expression analysis. Dr. Christoph Koenig, Nanostring Technologies, Seattle<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"104\">\n<p>15.00-15.10<\/p>\n<\/td>\n<td width=\"593\">\n<p><em>Closing remarks by Prof. Peter Lakatos<\/em><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Semmelweis Symposium &#8211; 2018 <a href=\"https:\/\/semmelweis.hu\/symposium\/files\/2018\/10\/Semmelweis-Symposium-program-v20181009.pdf\" target=\"_blank\" rel=\"noopener\">Semmelweis Symposium 2018 program download<\/a> New approaches in personalized medicine: From prenatal testing to targeted tumor therapy Budapest, November 8-9, 2018 Basic Science Center, Semmelweis University, Budapest (T\u0171zolt\u00f3 37-43, Budapest, 1094, Hungary) Chairperson: Prof. P\u00e9ter Lakatos 8th November 9.00-9.15 Opening ceremony 9.15-10.55 Section I. \u2013 Personalized Oncology I. 9.15-9.35 Personalized medicine: What does that mean? Istv\u00e1n &hellip;<\/p>\n","protected":false},"author":101412,"featured_media":0,"parent":1587,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-1590","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/1590","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/users\/101412"}],"replies":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/comments?post=1590"}],"version-history":[{"count":10,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/1590\/revisions"}],"predecessor-version":[{"id":1829,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/1590\/revisions\/1829"}],"up":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/1587"}],"wp:attachment":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/media?parent=1590"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/categories?post=1590"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/tags?post=1590"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}